Developer docs
API playgroundTry for free, no card

Search company profiles

MyCareGorithm

Full company profile

uuid000nzuh

Namestring
MyCareGorithm
Legal namestring
MyCareGorithm, LLC
Company typeenum
Private
Founded yearint
2021
Descriptiontext

MyCareGorithm, LLC is a U.S.-based private digital health company founded in 2021 and headquartered in Watchung, New Jersey, that builds a cloud-based visual consultation platform exclusively for oncology. The platform translates complex cancer diagnoses, staging, and treatment pathways into 3D models, annotated graphics, animated treatment pathways, and structured dashboards intended to be used inside the 10–15 minute consultation window. Its content library comprises 19 disease-specific modules covering 23 cancer types — including prostate, breast, lung, thyroid, pancreatic, colorectal, brain, melanoma, myeloma, and sarcoma — co-developed with oncology specialists and aligned to clinical guidelines. It also offers take-home resources and EHR integration, and a Diagnosis & Staging Module for myeloma built with the Leukemia & Lymphoma Society.

The company's primary customers are U.S. healthcare institutions — cancer centers, hospitals, and oncology practices — reached through an enterprise field sales motion supplemented by conference presence at events such as Astro 2025, the World Conference on Thyroid Cancer, and CMCN 2025. Pilots and case studies have been published with Moffitt Cancer Center, Mount Sinai Tisch Cancer Center, University of Virginia Cancer Center, and NYU Perlmutter Cancer Center, reporting 95–97% patient understanding improvement, 96% recommendation rates, and 100% provider willingness to integrate. MyCareGorithm generates revenue through a quote-based multi-year SaaS subscription model targeting institutions and oncology practices, with no public price list disclosed. The company reports 11–50 employees, no disclosed external funding beyond its participation in the CancerX Startup Accelerator (2026), and physician leadership under CEO and Co-Founder Louis Harrison, MD, FASTRO.

Short descriptiontext

MyCareGorithm is a physician-led U.S. digital health company that sells a cloud-based, EHR-integrated oncology consultation platform with 19 visual modules spanning 23 cancer types to U.S. cancer centers, hospitals, and oncology practices via multi-year enterprise SaaS subscriptions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWatchung, United States
HQ citystring
Watchung
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology consultation software, visual patient education, cancer treatment visualization, clinical decision support, patient engagement platform
Industry1 code
PRIMARYHLACAGAH
Oncology Pathways & Precision Medicine Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Health Services8000
Product category
Oncology Clinical Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Cloud-based platform subscription model for healthcare institutions, oncology practices, and cancer centers. Pricing is quote-based with no public price list disclosed.

mycaregorithm.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Quote-based enterprise pricing for healthcare institutions
ModelSubscriptionBilling cadenceMulti-year contract
Notes

No public pricing tiers or price points are listed. Sales process begins with a demo request via the website.

mycaregorithm.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

MyCareGorithm provides a cloud-based visual consultation platform for oncology that translates complex cancer information into 3D anatomical models, annotated clinical graphics, and animated treatment pathway visualizations. The platform equips oncologists with disease-specific modules covering 23 cancer types, structured consultation workflows, EHR integration, and personalized take-home patient resources to improve comprehension and informed consent.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 12 values shown
  • 95% of patients noted visual tools enhanced their understanding of their disease
+11 more records
Product overview1 text field

MyCareGorithm is a cloud-based digital consultation platform for oncology care. The core platform provides visual learning tools, a structured dashboard, and multimedia content library to enhance doctor-patient communication during cancer consultations. The product portfolio consists of 19 disease-specific modules covering 23 cancer types: Anal Cancer, Bladder Cancer, Brain Cancer, Breast Cancer, Cervix/Uterus Cancer, Colon Cancer, Kidney Cancer, Larynx/Oral Cavity Cancer, Lung Cancer, Melanoma, Myeloma, Oropharynx/Nasopharynx Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Stomach/Esophagus Cancer, and Thyroid Cancer. These modules provide visual treatment pathways, staging explanations, and comparative treatment option displays. The platform also includes Take-Home Resources that allow patients to access personalized summaries after consultations. The system integrates with EHR systems for real-time patient data access.

Product and service2 records
1MyCareGorithm Platform
CategoryOncology Clinical Software
Description

Cloud-based SaaS platform that equips oncologists with 3D anatomical models, annotated clinical graphics, animated treatment pathway visualizations, EHR integration, a structured consultation dashboard, AI-supported knowledge retrieval, and personalized patient take-home resources. Designed for cancer centers, hospitals, and oncology practices.

2Disease-Specific Cancer Modules (19 modules covering 23 cancer types)
CategoryClinical Content Modules
Description

Curated set of 19 disease-specific modules covering 23 cancer types, providing oncologists with pre-built visual content for breast cancer, head and neck cancer, lung cancer, gastrointestinal cancers, gynecologic cancers, genitourinary cancers, hematologic malignancies, melanoma, sarcoma, pediatric cancers, and others. Each module includes 3D models, annotated graphics, and animated treatment pathways.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-05
Description

MyCareGalgorithm, LLC and the THANC Foundation partnered to redefine the standard of care for more than 50,000 Americans and over 300,000 patients worldwide undergoing consultation for newly diagnosed thyroid cancer. The collaboration brings novel visual learning tools to the doctor-patient interaction. Cloud-based tools transform the consultation into a multimedia experience allowing patients to understand options for care, make informed decisions, and accomplish these goals with comprehensiveness, confidence, and efficiency. Dr. Mark Urken, Professor and former chairman of the Department of Otolaryngology Head and Neck Surgery at Icahn School of Medicine at Mount Sinai and Founder/Medical Advisor to THANC Foundation, provided expert endorsement of the thyroid module.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Conducted a case study with 20 localized pancreatic cancer patients aged 54-89 years. The study analyzed how a visual consultation tool influenced understanding of diagnosis and treatment. Results showed 88% of patients strongly agreed the tool impacted understanding of disease and treatment plan, and 100% strongly agreed it enhanced their confidence in the provider's care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Conducted a pilot study assessing the impact of digital visual tools on 32 English-speaking breast cancer patients' understanding of their disease and treatment recommendations during initial radiation oncology consultation. Study demonstrated enhanced patient understanding and improved clinical team engagement quality.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IRB-approved study evaluating the effectiveness of the digital health tool for both patients and physicians. 31 patients, 12 companions, and 2 physicians completed surveys to evaluate their experience.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

IRB-approved study with patients and caregivers receiving head and neck cancer radiation. Patients underwent initial consultation using the digital tool and completed surveys to evaluate their understanding of their disease.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

MyCareGalgorithm's Diagnosis & Staging Module for myeloma was developed in collaboration with the Leukemia & Lymphoma Society (LLS), guiding oncologists through a step-by-step visual narrative including real-time annotations on patient-specific scans, simplified explanations of antibody chains, M-protein formation, and myeloma staging criteria.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Cloud-based interactive 3D human anatomy and medical visualization platform used for patient education and clinical training. Comparable to MyCareGorithm's 3D model and animation capabilities, with overlapping use cases in explaining diagnoses through visualization, though not oncology-specialized.

TypeBroad incumbent
Description

Provider of point-of-care health education content delivered via digital screens and tablets in physician offices, including specialty practices. Overlaps with MyCareGorithm's in-exam-room visual education mission but at a broader primary-care and multi-specialty footprint.

TypeBroad incumbent
Description

Largest point-of-care patient education and engagement platform in US physician offices and health systems. Comparable as a broader patient education incumbent with established hospital relationships, though its content is less oncology-specialized than MyCareGorithm's.

TypeBroad incumbent
Description

Long-established patient education and consumer health content provider widely integrated into EHRs and hospital systems. Comparable as the legacy default for written/visual patient education that MyCareGorithm positions against with its oncology-specialized 3D consultation workflow.

TypeBroad incumbent
Description

Public, scaled patient intake and engagement platform deployed across thousands of provider organizations with deep EHR integrations. Comparable as a healthcare SaaS incumbent that hospitals may already pay for, presenting both competitive overlap and a channel partnership opportunity for oncology content.

TypeBroad incumbent
Description

Major patient education content vendor whose evidence-based materials are licensed by health systems and EHRs. Comparable as a substitute supplier of patient education content for hospitals; oncology-specific 3D visualization differentiates MyCareGorithm from Healthwise's mostly text-and-video library.

TypeDirect peer
Description

Patient-reported outcomes and engagement platform deployed by oncology practices to capture symptoms, deliver education, and support remote monitoring. Comparable to MyCareGorithm in that both serve cancer centers with structured patient education and engagement tools integrated into the consultation workflow.

TypeBroad incumbent
Description

Incumbent patient engagement platform used by hundreds of hospitals to deliver education, discharge planning, and interactive patient experiences. Comparable as a broader enterprise patient engagement incumbent that MyCareGorithm would need to displace or partner with inside oncology service lines.

9Carevive
TypeDirect peer
Description

Oncology-specific patient management platform providing personalized care plans, symptom management, and remote patient monitoring. Overlaps with MyCareGorithm in delivering oncology-tailored patient education and post-consultation engagement, with comparable EHR integration requirements.

10ClinicalPath (formerly Via Oncology)
TypeDirect peer
Description

Elsevier-owned oncology clinical decision support and pathways platform used by cancer centers to standardize treatment decisions. Directly comparable to MyCareGorithm's oncology decision support and care pathway visualization focus, though it is structured around evidence-based pathway selection rather than patient-facing visual consultation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MyCareGorithm

Oncology Clinical Softwaremycaregorithm.com

MyCareGorithm is a physician-led U.S. digital health company that sells a cloud-based, EHR-integrated oncology consultation platform with 19 visual modules spanning 23 cancer types to U.S. cancer centers, hospitals, and oncology practices via multi-year enterprise SaaS subscriptions.

What MyCareGorithm does

MyCareGorithm, LLC is a U.S.-based private digital health company founded in 2021 and headquartered in Watchung, New Jersey, that builds a cloud-based visual consultation platform exclusively for oncology. The platform translates complex cancer diagnoses, staging, and treatment pathways into 3D models, annotated graphics, animated treatment pathways, and structured dashboards intended to be used inside the 10–15 minute consultation window. Its content library comprises 19 disease-specific modules covering 23 cancer types — including prostate, breast, lung, thyroid, pancreatic, colorectal, brain, melanoma, myeloma, and sarcoma — co-developed with oncology specialists and aligned to clinical guidelines. It also offers take-home resources and EHR integration, and a Diagnosis & Staging Module for myeloma built with the Leukemia & Lymphoma Society.

The company's primary customers are U.S. healthcare institutions — cancer centers, hospitals, and oncology practices — reached through an enterprise field sales motion supplemented by conference presence at events such as Astro 2025, the World Conference on Thyroid Cancer, and CMCN 2025. Pilots and case studies have been published with Moffitt Cancer Center, Mount Sinai Tisch Cancer Center, University of Virginia Cancer Center, and NYU Perlmutter Cancer Center, reporting 95–97% patient understanding improvement, 96% recommendation rates, and 100% provider willingness to integrate. MyCareGorithm generates revenue through a quote-based multi-year SaaS subscription model targeting institutions and oncology practices, with no public price list disclosed. The company reports 11–50 employees, no disclosed external funding beyond its participation in the CancerX Startup Accelerator (2026), and physician leadership under CEO and Co-Founder Louis Harrison, MD, FASTRO.

MyCareGorithm firmographics

Firmographics
Name
MyCareGorithm
Legal name
MyCareGorithm, LLC
Website
https://mycaregorithm.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
MyCareGorithm is a physician-led U.S. digital health company that sells a cloud-based, EHR-integrated oncology consultation platform with 19 visual modules spanning 23 cancer types to U.S. cancer centers, hospitals, and oncology practices via multi-year enterprise SaaS subscriptions.
Ownership category
akta.pro rank

MyCareGorithm industry classification

Industry
Product category
Oncology Clinical Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAGAH
Oncology Pathways & Precision Medicine Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

  • Oncology consultation software
  • Visual patient education
  • Cancer treatment visualization
  • Clinical decision support
  • Patient engagement platform

Where MyCareGorithm is headquartered

Location

Headquarters

HQ city
Watchung
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MyCareGorithm business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS Platform Subscription: Cloud-based platform subscription model for healthcare institutions, oncology practices, and cancer centers. Pricing is quote-based with no public price list disclosed.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractQuote-based enterprise pricing for healthcare institutions

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

MyCareGorithm product offering

Product offering

Core offering

MyCareGorithm provides a cloud-based visual consultation platform for oncology that translates complex cancer information into 3D anatomical models, annotated clinical graphics, and animated treatment pathway visualizations. The platform equips oncologists with disease-specific modules covering 23 cancer types, structured consultation workflows, EHR integration, and personalized take-home patient resources to improve comprehension and informed consent.

Product overview

MyCareGorithm is a cloud-based digital consultation platform for oncology care. The core platform provides visual learning tools, a structured dashboard, and multimedia content library to enhance doctor-patient communication during cancer consultations. The product portfolio consists of 19 disease-specific modules covering 23 cancer types: Anal Cancer, Bladder Cancer, Brain Cancer, Breast Cancer, Cervix/Uterus Cancer, Colon Cancer, Kidney Cancer, Larynx/Oral Cavity Cancer, Lung Cancer, Melanoma, Myeloma, Oropharynx/Nasopharynx Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Stomach/Esophagus Cancer, and Thyroid Cancer. These modules provide visual treatment pathways, staging explanations, and comparative treatment option displays. The platform also includes Take-Home Resources that allow patients to access personalized summaries after consultations. The system integrates with EHR systems for real-time patient data access.

Differentiator

Problem solved

Functional benefit

Products and services

  • MyCareGorithm Platform Cloud-based SaaS platform that equips oncologists with 3D anatomical models, annotated clinical graphics, animated treatment pathway visualizations, EHR integration, a structured consultation dashboard, AI-supported knowledge retrieval, and personalized patient take-home resources. Designed for cancer centers, hospitals, and oncology practices.
  • Disease-Specific Cancer Modules (19 modules covering 23 cancer types) Curated set of 19 disease-specific modules covering 23 cancer types, providing oncologists with pre-built visual content for breast cancer, head and neck cancer, lung cancer, gastrointestinal cancers, gynecologic cancers, genitourinary cancers, hematologic malignancies, melanoma, sarcoma, pediatric cancers, and others. Each module includes 3D models, annotated graphics, and animated treatment pathways.

Quantifiable outcome

  • 95% of patients noted visual tools enhanced their understanding of their disease
  • +11 more outcomes

Companies that use MyCareGorithm

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

MyCareGorithm technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

MyCareGorithm partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and supporting.

  • THANC (Thyroid, Head and Neck Cancer) FoundationcoreStrategic or Co-development Partner · 5 February 2026MyCareGalgorithm, LLC and the THANC Foundation partnered to redefine the standard of care for more than 50,000 Americans and over 300,000 patients worldwide undergoing consultation for newly diagnosed thyroid cancer. The collaboration brings novel visual learning tools to the doctor-patient interaction. Cloud-based tools transform the consultation into a multimedia experience allowing patients to understand options for care, make informed decisions, and accomplish these goals with comprehensiveness, confidence, and efficiency. Dr. Mark Urken, Professor and former chairman of the Department of Otolaryngology Head and Neck Surgery at Icahn School of Medicine at Mount Sinai and Founder/Medical Advisor to THANC Foundation, provided expert endorsement of the thyroid module.
  • Moffitt Cancer CentercoreStrategic or Co-development PartnerConducted a case study with 20 localized pancreatic cancer patients aged 54-89 years. The study analyzed how a visual consultation tool influenced understanding of diagnosis and treatment. Results showed 88% of patients strongly agreed the tool impacted understanding of disease and treatment plan, and 100% strongly agreed it enhanced their confidence in the provider's care.
  • Mount Sinai Tisch Cancer CentercoreStrategic or Co-development PartnerConducted a pilot study assessing the impact of digital visual tools on 32 English-speaking breast cancer patients' understanding of their disease and treatment recommendations during initial radiation oncology consultation. Study demonstrated enhanced patient understanding and improved clinical team engagement quality.
  • University of Virginia Cancer CentercoreStrategic or Co-development PartnerIRB-approved study evaluating the effectiveness of the digital health tool for both patients and physicians. 31 patients, 12 companions, and 2 physicians completed surveys to evaluate their experience.
  • NYU Perlmutter Cancer CentercoreStrategic or Co-development PartnerIRB-approved study with patients and caregivers receiving head and neck cancer radiation. Patients underwent initial consultation using the digital tool and completed surveys to evaluate their understanding of their disease.
  • Leukemia & Lymphoma Society (LLS)supportingStrategic or Co-development PartnerMyCareGalgorithm's Diagnosis & Staging Module for myeloma was developed in collaboration with the Leukemia & Lymphoma Society (LLS), guiding oncologists through a step-by-step visual narrative including real-time annotations on patient-specific scans, simplified explanations of antibody chains, M-protein formation, and myeloma staging criteria.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

MyCareGorithm competitors and assessment

Company assessment

Emerging players

  • BioDigital: Cloud-based interactive 3D human anatomy and medical visualization platform used for patient education and clinical training. Comparable to MyCareGorithm's 3D model and animation capabilities, with overlapping use cases in explaining diagnoses through visualization, though not oncology-specialized.

Broad incumbents

  • Outcome Health: Provider of point-of-care health education content delivered via digital screens and tablets in physician offices, including specialty practices. Overlaps with MyCareGorithm's in-exam-room visual education mission but at a broader primary-care and multi-specialty footprint.
  • PatientPoint: Largest point-of-care patient education and engagement platform in US physician offices and health systems. Comparable as a broader patient education incumbent with established hospital relationships, though its content is less oncology-specialized than MyCareGorithm's.
  • Krames (Staywell): Long-established patient education and consumer health content provider widely integrated into EHRs and hospital systems. Comparable as the legacy default for written/visual patient education that MyCareGorithm positions against with its oncology-specialized 3D consultation workflow.
  • Phreesia: Public, scaled patient intake and engagement platform deployed across thousands of provider organizations with deep EHR integrations. Comparable as a healthcare SaaS incumbent that hospitals may already pay for, presenting both competitive overlap and a channel partnership opportunity for oncology content.
  • Healthwise: Major patient education content vendor whose evidence-based materials are licensed by health systems and EHRs. Comparable as a substitute supplier of patient education content for hospitals; oncology-specific 3D visualization differentiates MyCareGorithm from Healthwise's mostly text-and-video library.
  • GetWellNetwork: Incumbent patient engagement platform used by hundreds of hospitals to deliver education, discharge planning, and interactive patient experiences. Comparable as a broader enterprise patient engagement incumbent that MyCareGorithm would need to displace or partner with inside oncology service lines.

Direct peers

  • Noona: Patient-reported outcomes and engagement platform deployed by oncology practices to capture symptoms, deliver education, and support remote monitoring. Comparable to MyCareGorithm in that both serve cancer centers with structured patient education and engagement tools integrated into the consultation workflow.
  • Carevive: Oncology-specific patient management platform providing personalized care plans, symptom management, and remote patient monitoring. Overlaps with MyCareGorithm in delivering oncology-tailored patient education and post-consultation engagement, with comparable EHR integration requirements.
  • ClinicalPath (formerly Via Oncology): Elsevier-owned oncology clinical decision support and pathways platform used by cancer centers to standardize treatment decisions. Directly comparable to MyCareGorithm's oncology decision support and care pathway visualization focus, though it is structured around evidence-based pathway selection rather than patient-facing visual consultation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

MyCareGorithm social profiles

Digital presence

MyCareGorithm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MyCareGorithm leadership team

Management profile

Number of profiles

Profiles1 record

MyCareGorithm funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MyCareGorithm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyCareGorithm

What does MyCareGorithm do?

MyCareGorithm provides a cloud-based visual consultation platform for oncology that translates complex cancer information into 3D anatomical models, annotated clinical graphics, and animated treatment pathway visualizations. The platform equips oncologists with disease-specific modules covering 23 cancer types, structured consultation workflows, EHR integration, and personalized take-home patient resources to improve comprehension and informed consent.

Is MyCareGorithm a public or private company?

MyCareGorithm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MyCareGorithm founded?

MyCareGorithm was founded in 2021. It employs 11 to 50 people.

Where is MyCareGorithm based?

MyCareGorithm is headquartered in Watchung, United States, in the North America region.

How does MyCareGorithm make money?

One revenue line is on record: saaS Platform Subscription.

Who are MyCareGorithm's main competitors?

BioDigital is listed as an emerging player. Broad incumbents are Outcome Health, PatientPoint, Krames (Staywell), Phreesia, Healthwise and GetWellNetwork. Direct peers are Noona, Carevive and ClinicalPath (formerly Via Oncology).

Does MyCareGorithm have an API?

No public API is recorded for MyCareGorithm.

What industry is MyCareGorithm in?

MyCareGorithm's product category is Oncology Clinical Software. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support. Its NAICS code is 54151 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales